¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2019 ´ëÇѹ̻ý¹°ÇÐȸ Ãß°èÇмú´ëȸ : 2019-10-17

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2019 ´ëÇѹ̻ý¹°ÇÐȸ Ãß°èÇмú´ëȸ : 2019-10-17
±³À°ÀÏÀÚ : 2019-10-17
±³À°Àå¼Ò : °Ç±¹´ëÇб³ »õõ³â°ü ¿ì°î±¹Á¦È¸ÀÇÀå  
±³À°ÁÖÁ¦ : 2019 ´ëÇѹ̻ý¹°ÇÐȸ Ãß°èÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇѹ̻ý¹°ÇÐȸ
´ã´çÀÚ : ÃÖ¼¼ÀÎ
¿¬¶ôó : 02-887-3062  
À̸ÞÀÏ : ksm@ksmkorea.org      
±³À°Á¾·ù : ¹Ì»ý¹°ÇР     
Âü¼®¿¹»óÀοø : 250¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 50ºÐ  
¼¼ºÎ¼ö°­·á : 200,000¿ø      
ºñ°í »çÀüµî·Ï  * ÇÐȸȸ¿ø ±³¼ö/ÀÏ¹Ý – 100,000¿ø Çлý – 60,000¿ø  * ÇÐȸºñȸ¿ø ±³¼ö/ÀÏ¹Ý – 150,000¿ø Çлý – 80,000¿ø   ÇöÀåµî·Ï  * ÇÐȸȸ¿ø ±³¼ö/ÀÏ¹Ý – 150,000¿ø Çлý – 80,000¿ø  * ÇÐȸºñȸ¿ø ±³¼ö/ÀÏ¹Ý – 200,000¿ø Çлý – 90,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-17 ¿ì°î±¹Á¦È¸ÀÇÀå 09:30~10:00 ¿¬±¸À±¸®  Basil D¡¯souza(Council of Asian Science Editors) 
±³À°½Ã°£ 10-17 ¿ì°î±¹Á¦È¸ÀÇÀå 10:00~10:30 ±¹³» ¹Ì»ý¹°ÇÐ ±³À°ÇöȲ  À±ÁÖõ(ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ) 
±³À°½Ã°£ 10-17 ¿ì°î±¹Á¦È¸ÀÇÀå 10:30~11:00 ±¹¿Ü ¹Ì»ý¹°ÇÐ ±³À°ÇöȲ  À¯½Â¹Î(À»Áö´ëÇб³ ÀÇ°ú´ëÇÐ) 
±³À°½Ã°£ 10-17 ¿ì°î±¹Á¦È¸ÀÇÀå 11:00~11:30 ¹Ì»ý¹°Çб³À°ÀÇ ¹Ì·¡  ÀÌÀ¯Ã¶ ¿Ü(°æºÏ´ëÇб³ ÀÇ°ú´ëÇÐ ¿Ü) 
±³À°½Ã°£ 10-17 ¿ì°î±¹Á¦È¸ÀÇÀå 11:45~12:05 Æ¯°­  ÃÖ¸í½Ä(¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ) 
±³À°½Ã°£ 10-17 ¿ì°î±¹Á¦È¸ÀÇÀå 12:05~12:35 Innovative idea for development of noble drug, VSF and diagnostic kits in ImmuneMed.  ±èÀ±¿ø(À̹ø޵å) 
Åä·Ð 10-17 ¿ì°î±¹Á¦È¸ÀÇÀå 13:30~14:00 Poster Discussion  ½Å¼ºÀç,½Å¹Î°æ(¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ, °æ»ó´ëÇб³ ÀÇ°ú´ëÇÐ) 
±³À°½Ã°£ 10-17 ¿ì°î±¹Á¦È¸ÀÇÀå 14:00~14:30 Three-year follow-up study on the antibody responses in Korean MERS patients  Á¶³²Çõ(¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ) 
±³À°½Ã°£ 10-17 ¿ì°î±¹Á¦È¸ÀÇÀå 14:30~15:00 Recent trends in HCV research  ½ÅÀÇö(Ä«À̽ºÆ®) 
±³À°½Ã°£ 10-17 ¿ì°î±¹Á¦È¸ÀÇÀå 15:00~15:30 Microneedle Vaccines: Novel Strategies to Counter emerging and re-emerging Infectious Diseases  ÀÌÀç¸é(¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ) 
±³À°½Ã°£ 10-17 ¿ì°î±¹Á¦È¸ÀÇÀå 15:30~16:00 Influenza virus infections from neglected hosts  ¼Û´ë¼·(°í·Á´ëÇб³ ¾àÇдëÇÐ) 
±³À°½Ã°£ 10-17 ¿ì°î±¹Á¦È¸ÀÇÀå 16:15~16:45 Mechanism of mycobacterial persister formation: new drug-targets for tuberculosis  ¾îÇüÁø(Keck School of Medicine of USC) 
±³À°½Ã°£ 10-17 ¿ì°î±¹Á¦È¸ÀÇÀå 16:45~17:15 Mechanisms and Consequences of Macrophage Cell Death in TB.  Hardy Kornfeld(University of Massachusetts Medical School) 
±³À°½Ã°£ 10-17 ¿ì°î±¹Á¦È¸ÀÇÀå 17:15~17:45 Understanding microbial response to antibiotics through chemical biology  ÀÌ¿ø½Ä(¼º±Õ°ü´ë ¾àÇдëÇÐ) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2019 ´ëÇѹ̻ý¹°ÇÐȸ Ãß°èÇмú´ëȸ : 2019-10-17""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ The 63rd Annual Congress of the Korean Orthopaedic Association 2019 : 2019-10-17
´ÙÀ½±Û Á¦2ȸ À»Áö´ëÇб³ À»Áöº´¿ø ºñ´¢ÀÇÇаú °³¿øÀÇ ¿¬¼ö°­Á : 2019-10-17
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
123 °æºÏ ´ëÇÑÁ¾¾ç³»°úÇÐȸ Best of ASCO 2018 in Korea : 2018-08-25 0 523 2018-07-28
122 ´ëÀü ´ëÇÑ°»³â±âÇÐȸ 2018 ÇÏ°è¿öÅ©¼¥ : 2018-08-25 0 384 2018-07-28
121 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø ¼ö¸éÀÇÇÐ:´ÙÇÐÁ¦ Áø·áÀÇ ÀüÇü : 2018-08-25 0 797 2018-07-28
120 ´ë±¸ Ä¥°î°æºÏ´ëÇб³º´¿ø 2018³â È£½ºÇǽºÀÇ·á±â°ü Á¾»çÀÚ º¸¼ö±³À°°úÁ¤ : 2018-08-25 0 1,441 2018-07-28
119 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ±³À°ÀÚ ¼¼¹Ì³ª : 2018-08-25 0 666 2018-07-28
118 ¼­¿ï Çѱ¹À¯¹æ¾ÏÇÐȸ 2018 School of Breast Disease(Day 1) : 2018-08-25 0 578 2018-07-28
117 ´ëÀü ´ëÇѳëÀκ´ÇÐȸ ³ëÀÎȯÀÚÀÇ Ä¡·á¿Í º¯È­ÇÏ´Â ÀÇ·á : 2018-08-25 0 1,182 2018-07-28
116 ºÎ»ê 2018³â ´ëÇÑÁßȯÀÚÀÇÇÐȸ ºÎ»ê¿ï»ê°æ³²Áöȸ NIV ¿öÅ©¼¥ : 2018-08-25 0 892 2018-07-28
115 ÀÎõ 2018³â ´ëÇѺҾÈÀÇÇÐȸ Çϰ迬¼ö±³À° : 2018-08-25 0 619 2018-07-28
114 ¼­¿ï Çѱ¹¿©ÀÚÀÇ»çȸ ¿°Áõ¼º Àå Áúȯ Áø´Ü°ú Ä¡·á / ³»½Ã°æ ¹ßÀü ¿ª»ç : 2018-08-25 0 539 2018-07-28
113 ´ë±¸ ´ëÇѵÎÅëÇÐȸ ´ë±¸, °æºÏÁö¿ª º¸¼ö±³À°(¸¸¼ºÆíµÎÅë Áø´Ü ¹× Ä¡·á 6 ´Ü°è) : 2018-08-25 0 757 2018-07-28
112 °æ±â Á¦ 7ȸ ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¿ò : 2018-08-25 0 611 2018-07-28
111 ¼­¿ï Á¦2ȸ ´ëÇѼҾÆÁßȯÀÚÀÇÇÐȸ ¼Ò¾Æ±â°èȯ±â ¿öÅ©¼ó ¿ÀÀü session(8.25) : 2018-08-25 0 998 2018-07-28
110 ¼­¿ï Á¦2ȸ ´ëÇѼҾÆÁßȯÀÚÀÇÇÐȸ ¼Ò¾Æ±â°èȯ±â ¿öÅ©¼ó Interactive workshop(8.25) : 2018-08-25 0 700 2018-07-28
109 ±¤ÁÖ ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ Á¦99Â÷ Àü³²ºÏÁöȸ ¿¬¼ö°­Á : 2018-08-25 0 621 2018-07-28
1401 | 1402 | 1403 | 1404 | 1405 | 1406 | 1407 | 1408 | 1409 | 1410
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷